BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our Industry eNewsletter FREE email:    
 Investor News
Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings
Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions 
Start-Ups
IPO News
IPO
 


Clinical - Phase III
Baxter International, Inc. (BAX) Drug BAX 111 Treats 100 Percent Of Bleeding Episodes In Small Phase 3 Trial 4/16/2014 6:53:42 AM    More...
Boehringer Ingelheim Corporation Rethinks Hepatitis Business, Braces For A Rough 2014 4/16/2014 8:09:31 AM    More...
Volasertib, Boehringer Ingelheim Corporation´s Investigational Treatment Of Acute Myeloid Leukaemia, Is Granted "Orphan Drug Designation" In The EU And The U.S. 4/17/2014 9:42:55 AM    More...
Dynavax Technologies Corporation (DVAX) Initiates Phase 3 Study Of HEPLISAV-B™ 4/16/2014 10:14:40 AM    More...
AbbVie (ABBV)'s Experimental Hepatitis C Regimen Associated With High Cure Rates In Late-Stage Studies 4/14/2014 6:22:40 AM    More...
BioAlliance Pharma Announces A New Positive DSMB Recommendation To Continue Its Phase 3 Clinical Trial With Livatag® In Primary Liver Cancer 4/14/2014 4:04:07 PM    More...
BioAlliance Pharma Announces A New Positive DSMB Recommendation To Continue Its Phase III Clinical Trial With Livatag® In Primary Liver Cancer 4/14/2014 2:11:16 PM    More...
Enanta Pharmaceuticals, Inc. Announces Detailed Data From TURQUOISE-II Study In Chronic Hepatitis C Patients With Cirrhosis Being Presented At The European Association For The Study Of The Liver (EASL) Meeting 4/14/2014 9:41:13 AM    More...
Ipsen (IPN.PA) Announces A First Set Of Results On Positive Phase III Clinical Study Of Dysport® In The Treatment Of Adults Suffering From Upper Limb Spasticity At The 8th World Congress For Neurorehabilitation In Istanbul 4/14/2014 9:38:54 AM    More...
Portola Pharmaceuticals, Inc. Announces Publication Of Phase 3 APEX Study Design And Rationale In American Heart Journal 4/14/2014 9:20:58 AM    More...
Mast Therapeutics (MSTX) Announces New Data Supporting MST-188 In Sickle Cell Disease 4/14/2014 8:18:59 AM    More...
Intercept Pharmaceuticals (ICPT) Reports Additional Positive Data From POISE Trial At EASL Late-Breaker Session 4/14/2014 6:37:05 AM    More...
Bristol-Myers Squibb Company (BMY)'s Hepatitis C Drug Cures Up To 90 Percent In Phase 3 Study 4/10/2014 6:50:16 AM    More...
Actinium Pharmaceuticals, Inc. (ATNM.OB) Analyst Report: High Potential Emerging Biopharmaceutical Firm Nearing Phase 3 Trial Commencement For Innovative Cancer Treatments 4/11/2014 9:03:49 AM    More...
Biogen Idec, Inc. (Massachusetts) (BIIB)'s Blood Disorder Drug Succeeds In Phase 3 Trial 4/10/2014 6:42:28 AM    More...
1234567
 

//-->